Oxford BioDynamics Plc (OXBOF)

USD 0.02

(-86.0%)

Revenue Summary of Oxford BioDynamics Plc

  • Oxford BioDynamics Plc's latest annual revenue in 2023 was 510 Thousand GBP , up 231.17% from previous year.
  • Oxford BioDynamics Plc's latest quarterly revenue in 2024 Q2 was 163.5 Thousand GBP , down 0.0% from previous quarter.
  • Oxford BioDynamics Plc reported a annual revenue of 154 Thousand GBP in annual revenue 2022, down -54.84% from previous year.
  • Oxford BioDynamics Plc reported a annual revenue of 341 Thousand GBP in annual revenue 2021, down -25.22% from previous year.
  • Oxford BioDynamics Plc reported a quarterly revenue of 163.5 Thousand GBP for 2024 Q1, down -43.62% from previous quarter.
  • Oxford BioDynamics Plc reported a quarterly revenue of 220 Thousand GBP for 2023 Q2, up 100.0% from previous quarter.

Annual Revenue Chart of Oxford BioDynamics Plc (2023 - 2013)

Historical Annual Revenue of Oxford BioDynamics Plc (2023 - 2013)

Year Revenue Revenue Growth
2023 510 Thousand GBP 231.17%
2022 154 Thousand GBP -54.84%
2021 341 Thousand GBP -25.22%
2020 456 Thousand GBP -49.72%
2019 907 Thousand GBP -23.52%
2018 1.18 Million GBP 0.25%
2017 1.18 Million GBP 8.43%
2016 1.09 Million GBP 55.41%
2015 702 Thousand GBP 6.53%
2014 659 Thousand GBP 88.29%
2013 350 Thousand GBP 0.0%

Peer Revenue Comparison of Oxford BioDynamics Plc

Name Revenue Revenue Difference
Capstone Therapeutics Corp. 48.35 Million USD 98.945%
Skye Bioscience, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.585%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -573.498%
BioStem Technologies, Inc. 16.68 Million USD 96.943%
Regen BioPharma, Inc. 236.56 Thousand USD -115.59%
CSL Limited 14.69 Billion USD 99.997%
Northwest Biotherapeutics, Inc. 1.93 Million USD 73.602%
Evofem Biosciences, Inc. 18.21 Million USD 97.201%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 22.551%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.767%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2794.274%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.625%
Intellipharmaceutics International Inc. 65.72 Thousand USD -675.925%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 91.359%
Marizyme, Inc. 645.81 Thousand USD 21.029%
Genus plc 668.8 Million USD 99.924%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.792%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -415.183%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -24.34%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -564.4%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1190.551%
MultiCell Technologies, Inc. 49.32 USD -1033963.26%
ONE Bio Corp. 52.29 Million USD 99.025%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.974%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -942.945%
Q BioMed Inc. 284.35 Thousand USD -79.355%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.277%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.649%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 8.555%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -628.571%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -50951.051%
Enzolytics Inc. 52.79 Thousand USD -865.982%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 16.191%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.958%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -263.657%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 17.393%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.939%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 48.884%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -115.59%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 62.747%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -7.656%
SYBLEU INC 11.69 Thousand USD -4260.465%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 93.452%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3823.077%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1190.029%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 84.685%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 92.348%
IntelGenx Technologies Corp. 1.03 Million USD 50.914%
Gelesis Holdings, Inc. 25.76 Million USD 98.021%
CSL Limited 14.8 Billion USD 99.997%
Cellectis S.A. 755 Thousand USD 32.45%